Prevalence and phenotypic characterization of ESBL producing E.coli and Klebsiella among the fecal isolates of normal population
暂无分享,去创建一个
[1] Y. Chander,et al. Carriage of ESBL and AmpC-Positive Enterobacteriaceae in Gastrointestinal Tract of Healthy Community Subjects and Hospitalized Patients and Detection of blaCTX-M Gene in ESBL Positive Isolates. , 2015 .
[2] Joseph M. Campos,et al. Extended-spectrum Beta-lactamases: A Brief Clinical Update , 2011, The Pediatric infectious disease journal.
[3] C. Rodrigues,et al. Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-abdominal infections across India (based on SMART study, 2007 data). , 2011, The Journal of the Association of Physicians of India.
[4] Zeina A Kanafani,et al. Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. , 2011, Mayo Clinic proceedings.
[5] P. Wayne. CLINICAL AND LABORATORY STANDARDS INSTITUTE. PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING , 2011 .
[6] B. Veeraraghavan,et al. Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India. , 2010, The Journal of the Association of Physicians of India.
[7] P. Collignon,et al. Colonisation with Escherichia coli resistant to “critically important” antibiotics: a high risk for international travellers , 2010, European Journal of Clinical Microbiology & Infectious Diseases.
[8] O. Cars,et al. Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamases: a Prospective Study with Swedish Volunteers , 2010, Antimicrobial Agents and Chemotherapy.
[9] I. Odenholt,et al. Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea , 2010, Scandinavian journal of infectious diseases.
[10] F. Baquero,et al. Antibiotic Coresistance in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae and In Vitro Activity of Tigecycline , 2006, Antimicrobial Agents and Chemotherapy.
[11] K. Angamuthu,et al. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. , 2005, Saudi medical journal.
[12] M. Kaufmann,et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. , 2004, The Journal of antimicrobial chemotherapy.
[13] P. Nordmann,et al. Emerging carbapenemases in Gram-negative aerobes. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[14] G. Jacoby,et al. Plasmid-determined AmpC-type beta-lactamases. , 2002, Antimicrobial agents and chemotherapy.
[15] B. Levin,et al. Minimizing potential resistance: a population dynamics view. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] J. Pagés,et al. Most Enterobacter aerogenes Strains in France Belong to a Prevalent Clone , 1999, Journal of Clinical Microbiology.
[17] C. Quentin,et al. Molecular epidemiology of a nosocomial outbreak due to SHV-4-producing strains of Citrobacter diversus , 1997, Journal of clinical microbiology.
[18] A. Medeiros,et al. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] D. Livermore. beta-Lactamases in laboratory and clinical resistance , 1995, Clinical microbiology reviews.
[20] G. Jacoby,et al. A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.
[21] R. Ambler,et al. The structure of beta-lactamases. , 1980, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[22] H. B. Woodruff,et al. Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces , 1969, Science.
[23] Howard Florey,et al. FURTHER OBSERVATIONS ON PENICILLIN , 1941 .